- The total securities market turnover for the Singapore Exchange (SGX) in March was S$29.65 billion.
- The total derivatives volume in March reached 27.37 million.
- The daily average volume for derivatives was recorded at 1.33 million.
- Market analysts have recommended 7 buys for stocks listed on SGX.
- There are 4 stocks with a hold recommendation from analysts.
- 5 stocks have been advised by market analysts to sell.
A look at SGX Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Singapore Exchange Limited (SGX) shows a positive long-term outlook. With strong ratings in Growth, Resilience, and Momentum, SGX demonstrates robust potential for future development and stability in the market. The company’s focus on growth opportunities, resilience in market fluctuations, and momentum in its performance indicates a promising path ahead for investors.
SGX‘s Smart Scores highlight its solid foundation and strategic positioning for long-term success. With a balanced combination of value, dividend, growth, resilience, and momentum scores, SGX appears well-equipped to navigate various market conditions and deliver sustained value to its stakeholders. As Singapore’s premier securities and derivatives exchange, SGX‘s commitment to excellence in services and technology underscores its reliability and attractiveness as an investment choice.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
